EMEA-002907-PIP01-20-M03 - paediatric investigation plan
Epcoritamab
PIPHuman
Key facts
- Active Substance
- Epcoritamab
- Therapeutic area
- Neoplasms benign, malignant and unspecified (incl cysts and polyps)
- Oncology
- Decision number
- P/0224/2024
- PIP number
- EMEA-002907-PIP01-20-M03
- Pharmaceutical form(s)
- Concentrate for solution for injection
- Solution for injection
- Condition(s) / indication(s)
- Treatment of mature B-cell malignancies
- Route(s) of administration
- Subcutaneous use
- Contact for public enquiries
AbbVie Ltd
E-mail: paediatricteam@abbvie.com
Tel. +44(0) 1628925033- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date